Dr. Lal PathLabs Q1 FY27 revenue up 19% YoY
after close1 source ↓written by the desknot a recommendation
- PathLabs reported
- 19.1% YoY revenue growth
- in Q1 FY27
- ₹797.70 crore
- ₹170.50 crore
- EBITDA rose
- 29%
- Total revenue reached
- ₹829.60 crore
Dr. Lal PathLabs reported a 19.1% YoY revenue growth to ₹797.70 crore in Q1 FY27, driven by strong demand in diagnostics. PAT increased 27.2% to ₹170.50 crore, reflecting improved operating efficiency and margin expansion. This robust performance may enhance investor sentiment in the diagnostics sector.
• Revenue growth from ₹669.80 crore in Q1 FY26
• EBITDA rose nearly 29%
• Total revenue reached ₹829.60 crore, up 18.9% YoY
Not investment advice. For informational purposes only.